Global Interventional Oncology Device Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Interventional Oncology Device refers to theOncology, like internal medicine, surgery, obstetrics and gynecology, and pediatrics, is a secondary discipline of clinical medicine. It is divided into oncology, oncology radiotherapy, and oncology surgery. Oncology is mainly engaged in medical treatment of various benign and malignant tumors; The Department of Radiation Oncology is mainly engaged in radiotherapy of tumors; oncology surgery provides surgery-based comprehensive treatment. Relevant departments of specialized cancer hospitals will be subdivided according to different parts, such as gastrointestinal oncology and lymphoma oncology in the oncology department; tumor surgery includes breast surgery, head and neck surgery, thoracic surgery, tumor gynecology, and abdominal surgery.
LPI (LP Information)' newest research report, the “Interventional Oncology Device Industry Forecast” looks at past sales and reviews total world Interventional Oncology Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Interventional Oncology Device sales for 2023 through 2029. With Interventional Oncology Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Oncology Device industry.
This Insight Report provides a comprehensive analysis of the global Interventional Oncology Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Oncology Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Interventional Oncology Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Oncology Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Oncology Device.
The global Interventional Oncology Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Interventional Oncology Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Interventional Oncology Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Interventional Oncology Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Interventional Oncology Device players cover AngioDynamics, Inc., BD, Boston Scientific Corporation, BTG Plc, Eckert & Ziegler BEBIG, HealthTronics, Inc., IceCure Medical, Medtronic PLC and Medwaves, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Oncology Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Interventional Oncology Device market?
What factors are driving Interventional Oncology Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Interventional Oncology Device market opportunities vary by end market size?
How does Interventional Oncology Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Interventional Oncology Device refers to theOncology, like internal medicine, surgery, obstetrics and gynecology, and pediatrics, is a secondary discipline of clinical medicine. It is divided into oncology, oncology radiotherapy, and oncology surgery. Oncology is mainly engaged in medical treatment of various benign and malignant tumors; The Department of Radiation Oncology is mainly engaged in radiotherapy of tumors; oncology surgery provides surgery-based comprehensive treatment. Relevant departments of specialized cancer hospitals will be subdivided according to different parts, such as gastrointestinal oncology and lymphoma oncology in the oncology department; tumor surgery includes breast surgery, head and neck surgery, thoracic surgery, tumor gynecology, and abdominal surgery.
LPI (LP Information)' newest research report, the “Interventional Oncology Device Industry Forecast” looks at past sales and reviews total world Interventional Oncology Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Interventional Oncology Device sales for 2023 through 2029. With Interventional Oncology Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Oncology Device industry.
This Insight Report provides a comprehensive analysis of the global Interventional Oncology Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Oncology Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Interventional Oncology Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Oncology Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Oncology Device.
The global Interventional Oncology Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Interventional Oncology Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Interventional Oncology Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Interventional Oncology Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Interventional Oncology Device players cover AngioDynamics, Inc., BD, Boston Scientific Corporation, BTG Plc, Eckert & Ziegler BEBIG, HealthTronics, Inc., IceCure Medical, Medtronic PLC and Medwaves, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Oncology Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Ablation Devices
- Embolization Devices
- Supporting Devices
- Next Generation Devices
- Hospitals
- Specialty Clinics and Ambulatory Surgical Centers
- Others (Homecare and Research Institutes)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AngioDynamics, Inc.
- BD
- Boston Scientific Corporation
- BTG Plc
- Eckert & Ziegler BEBIG
- HealthTronics, Inc.
- IceCure Medical
- Medtronic PLC
- Medwaves, Inc.
- Merit Medical Systems, Inc.
- Sanarus Technologies, Inc.
- Sirtex Medical Ltd.
- Sonacare Medical
- Terumo Corporation
- Trod Medical
- Cook Meidical LLC
What is the 10-year outlook for the global Interventional Oncology Device market?
What factors are driving Interventional Oncology Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Interventional Oncology Device market opportunities vary by end market size?
How does Interventional Oncology Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Interventional Oncology Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Interventional Oncology Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Interventional Oncology Device by Country/Region, 2018, 2022 & 2029
2.2 Interventional Oncology Device Segment by Type
2.2.1 Ablation Devices
2.2.2 Embolization Devices
2.2.3 Supporting Devices
2.2.4 Next Generation Devices
2.3 Interventional Oncology Device Sales by Type
2.3.1 Global Interventional Oncology Device Sales Market Share by Type (2018-2023)
2.3.2 Global Interventional Oncology Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Interventional Oncology Device Sale Price by Type (2018-2023)
2.4 Interventional Oncology Device Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics and Ambulatory Surgical Centers
2.4.3 Others (Homecare and Research Institutes)
2.5 Interventional Oncology Device Sales by Application
2.5.1 Global Interventional Oncology Device Sale Market Share by Application (2018-2023)
2.5.2 Global Interventional Oncology Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Interventional Oncology Device Sale Price by Application (2018-2023)
3 GLOBAL INTERVENTIONAL ONCOLOGY DEVICE BY COMPANY
3.1 Global Interventional Oncology Device Breakdown Data by Company
3.1.1 Global Interventional Oncology Device Annual Sales by Company (2018-2023)
3.1.2 Global Interventional Oncology Device Sales Market Share by Company (2018-2023)
3.2 Global Interventional Oncology Device Annual Revenue by Company (2018-2023)
3.2.1 Global Interventional Oncology Device Revenue by Company (2018-2023)
3.2.2 Global Interventional Oncology Device Revenue Market Share by Company (2018-2023)
3.3 Global Interventional Oncology Device Sale Price by Company
3.4 Key Manufacturers Interventional Oncology Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Interventional Oncology Device Product Location Distribution
3.4.2 Players Interventional Oncology Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTERVENTIONAL ONCOLOGY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Interventional Oncology Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Interventional Oncology Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Interventional Oncology Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Interventional Oncology Device Market Size by Country/Region (2018-2023)
4.2.1 Global Interventional Oncology Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Interventional Oncology Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Interventional Oncology Device Sales Growth
4.4 APAC Interventional Oncology Device Sales Growth
4.5 Europe Interventional Oncology Device Sales Growth
4.6 Middle East & Africa Interventional Oncology Device Sales Growth
5 AMERICAS
5.1 Americas Interventional Oncology Device Sales by Country
5.1.1 Americas Interventional Oncology Device Sales by Country (2018-2023)
5.1.2 Americas Interventional Oncology Device Revenue by Country (2018-2023)
5.2 Americas Interventional Oncology Device Sales by Type
5.3 Americas Interventional Oncology Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interventional Oncology Device Sales by Region
6.1.1 APAC Interventional Oncology Device Sales by Region (2018-2023)
6.1.2 APAC Interventional Oncology Device Revenue by Region (2018-2023)
6.2 APAC Interventional Oncology Device Sales by Type
6.3 APAC Interventional Oncology Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Interventional Oncology Device by Country
7.1.1 Europe Interventional Oncology Device Sales by Country (2018-2023)
7.1.2 Europe Interventional Oncology Device Revenue by Country (2018-2023)
7.2 Europe Interventional Oncology Device Sales by Type
7.3 Europe Interventional Oncology Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Interventional Oncology Device by Country
8.1.1 Middle East & Africa Interventional Oncology Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Interventional Oncology Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Interventional Oncology Device Sales by Type
8.3 Middle East & Africa Interventional Oncology Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interventional Oncology Device
10.3 Manufacturing Process Analysis of Interventional Oncology Device
10.4 Industry Chain Structure of Interventional Oncology Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Interventional Oncology Device Distributors
11.3 Interventional Oncology Device Customer
12 WORLD FORECAST REVIEW FOR INTERVENTIONAL ONCOLOGY DEVICE BY GEOGRAPHIC REGION
12.1 Global Interventional Oncology Device Market Size Forecast by Region
12.1.1 Global Interventional Oncology Device Forecast by Region (2024-2029)
12.1.2 Global Interventional Oncology Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Interventional Oncology Device Forecast by Type
12.7 Global Interventional Oncology Device Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AngioDynamics, Inc.
13.1.1 AngioDynamics, Inc. Company Information
13.1.2 AngioDynamics, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.1.3 AngioDynamics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AngioDynamics, Inc. Main Business Overview
13.1.5 AngioDynamics, Inc. Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Interventional Oncology Device Product Portfolios and Specifications
13.2.3 BD Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Interventional Oncology Device Product Portfolios and Specifications
13.3.3 Boston Scientific Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 BTG Plc
13.4.1 BTG Plc Company Information
13.4.2 BTG Plc Interventional Oncology Device Product Portfolios and Specifications
13.4.3 BTG Plc Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BTG Plc Main Business Overview
13.4.5 BTG Plc Latest Developments
13.5 Eckert & Ziegler BEBIG
13.5.1 Eckert & Ziegler BEBIG Company Information
13.5.2 Eckert & Ziegler BEBIG Interventional Oncology Device Product Portfolios and Specifications
13.5.3 Eckert & Ziegler BEBIG Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Eckert & Ziegler BEBIG Main Business Overview
13.5.5 Eckert & Ziegler BEBIG Latest Developments
13.6 HealthTronics, Inc.
13.6.1 HealthTronics, Inc. Company Information
13.6.2 HealthTronics, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.6.3 HealthTronics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 HealthTronics, Inc. Main Business Overview
13.6.5 HealthTronics, Inc. Latest Developments
13.7 IceCure Medical
13.7.1 IceCure Medical Company Information
13.7.2 IceCure Medical Interventional Oncology Device Product Portfolios and Specifications
13.7.3 IceCure Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 IceCure Medical Main Business Overview
13.7.5 IceCure Medical Latest Developments
13.8 Medtronic PLC
13.8.1 Medtronic PLC Company Information
13.8.2 Medtronic PLC Interventional Oncology Device Product Portfolios and Specifications
13.8.3 Medtronic PLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Medtronic PLC Main Business Overview
13.8.5 Medtronic PLC Latest Developments
13.9 Medwaves, Inc.
13.9.1 Medwaves, Inc. Company Information
13.9.2 Medwaves, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.9.3 Medwaves, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Medwaves, Inc. Main Business Overview
13.9.5 Medwaves, Inc. Latest Developments
13.10 Merit Medical Systems, Inc.
13.10.1 Merit Medical Systems, Inc. Company Information
13.10.2 Merit Medical Systems, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.10.3 Merit Medical Systems, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merit Medical Systems, Inc. Main Business Overview
13.10.5 Merit Medical Systems, Inc. Latest Developments
13.11 Sanarus Technologies, Inc.
13.11.1 Sanarus Technologies, Inc. Company Information
13.11.2 Sanarus Technologies, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.11.3 Sanarus Technologies, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sanarus Technologies, Inc. Main Business Overview
13.11.5 Sanarus Technologies, Inc. Latest Developments
13.12 Sirtex Medical Ltd.
13.12.1 Sirtex Medical Ltd. Company Information
13.12.2 Sirtex Medical Ltd. Interventional Oncology Device Product Portfolios and Specifications
13.12.3 Sirtex Medical Ltd. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sirtex Medical Ltd. Main Business Overview
13.12.5 Sirtex Medical Ltd. Latest Developments
13.13 Sonacare Medical
13.13.1 Sonacare Medical Company Information
13.13.2 Sonacare Medical Interventional Oncology Device Product Portfolios and Specifications
13.13.3 Sonacare Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sonacare Medical Main Business Overview
13.13.5 Sonacare Medical Latest Developments
13.14 Terumo Corporation
13.14.1 Terumo Corporation Company Information
13.14.2 Terumo Corporation Interventional Oncology Device Product Portfolios and Specifications
13.14.3 Terumo Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Terumo Corporation Main Business Overview
13.14.5 Terumo Corporation Latest Developments
13.15 Trod Medical
13.15.1 Trod Medical Company Information
13.15.2 Trod Medical Interventional Oncology Device Product Portfolios and Specifications
13.15.3 Trod Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Trod Medical Main Business Overview
13.15.5 Trod Medical Latest Developments
13.16 Cook Meidical LLC
13.16.1 Cook Meidical LLC Company Information
13.16.2 Cook Meidical LLC Interventional Oncology Device Product Portfolios and Specifications
13.16.3 Cook Meidical LLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Cook Meidical LLC Main Business Overview
13.16.5 Cook Meidical LLC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Interventional Oncology Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Interventional Oncology Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Interventional Oncology Device by Country/Region, 2018, 2022 & 2029
2.2 Interventional Oncology Device Segment by Type
2.2.1 Ablation Devices
2.2.2 Embolization Devices
2.2.3 Supporting Devices
2.2.4 Next Generation Devices
2.3 Interventional Oncology Device Sales by Type
2.3.1 Global Interventional Oncology Device Sales Market Share by Type (2018-2023)
2.3.2 Global Interventional Oncology Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Interventional Oncology Device Sale Price by Type (2018-2023)
2.4 Interventional Oncology Device Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics and Ambulatory Surgical Centers
2.4.3 Others (Homecare and Research Institutes)
2.5 Interventional Oncology Device Sales by Application
2.5.1 Global Interventional Oncology Device Sale Market Share by Application (2018-2023)
2.5.2 Global Interventional Oncology Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Interventional Oncology Device Sale Price by Application (2018-2023)
3 GLOBAL INTERVENTIONAL ONCOLOGY DEVICE BY COMPANY
3.1 Global Interventional Oncology Device Breakdown Data by Company
3.1.1 Global Interventional Oncology Device Annual Sales by Company (2018-2023)
3.1.2 Global Interventional Oncology Device Sales Market Share by Company (2018-2023)
3.2 Global Interventional Oncology Device Annual Revenue by Company (2018-2023)
3.2.1 Global Interventional Oncology Device Revenue by Company (2018-2023)
3.2.2 Global Interventional Oncology Device Revenue Market Share by Company (2018-2023)
3.3 Global Interventional Oncology Device Sale Price by Company
3.4 Key Manufacturers Interventional Oncology Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Interventional Oncology Device Product Location Distribution
3.4.2 Players Interventional Oncology Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTERVENTIONAL ONCOLOGY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Interventional Oncology Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Interventional Oncology Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Interventional Oncology Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Interventional Oncology Device Market Size by Country/Region (2018-2023)
4.2.1 Global Interventional Oncology Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Interventional Oncology Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Interventional Oncology Device Sales Growth
4.4 APAC Interventional Oncology Device Sales Growth
4.5 Europe Interventional Oncology Device Sales Growth
4.6 Middle East & Africa Interventional Oncology Device Sales Growth
5 AMERICAS
5.1 Americas Interventional Oncology Device Sales by Country
5.1.1 Americas Interventional Oncology Device Sales by Country (2018-2023)
5.1.2 Americas Interventional Oncology Device Revenue by Country (2018-2023)
5.2 Americas Interventional Oncology Device Sales by Type
5.3 Americas Interventional Oncology Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interventional Oncology Device Sales by Region
6.1.1 APAC Interventional Oncology Device Sales by Region (2018-2023)
6.1.2 APAC Interventional Oncology Device Revenue by Region (2018-2023)
6.2 APAC Interventional Oncology Device Sales by Type
6.3 APAC Interventional Oncology Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Interventional Oncology Device by Country
7.1.1 Europe Interventional Oncology Device Sales by Country (2018-2023)
7.1.2 Europe Interventional Oncology Device Revenue by Country (2018-2023)
7.2 Europe Interventional Oncology Device Sales by Type
7.3 Europe Interventional Oncology Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Interventional Oncology Device by Country
8.1.1 Middle East & Africa Interventional Oncology Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Interventional Oncology Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Interventional Oncology Device Sales by Type
8.3 Middle East & Africa Interventional Oncology Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interventional Oncology Device
10.3 Manufacturing Process Analysis of Interventional Oncology Device
10.4 Industry Chain Structure of Interventional Oncology Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Interventional Oncology Device Distributors
11.3 Interventional Oncology Device Customer
12 WORLD FORECAST REVIEW FOR INTERVENTIONAL ONCOLOGY DEVICE BY GEOGRAPHIC REGION
12.1 Global Interventional Oncology Device Market Size Forecast by Region
12.1.1 Global Interventional Oncology Device Forecast by Region (2024-2029)
12.1.2 Global Interventional Oncology Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Interventional Oncology Device Forecast by Type
12.7 Global Interventional Oncology Device Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AngioDynamics, Inc.
13.1.1 AngioDynamics, Inc. Company Information
13.1.2 AngioDynamics, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.1.3 AngioDynamics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AngioDynamics, Inc. Main Business Overview
13.1.5 AngioDynamics, Inc. Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Interventional Oncology Device Product Portfolios and Specifications
13.2.3 BD Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Interventional Oncology Device Product Portfolios and Specifications
13.3.3 Boston Scientific Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 BTG Plc
13.4.1 BTG Plc Company Information
13.4.2 BTG Plc Interventional Oncology Device Product Portfolios and Specifications
13.4.3 BTG Plc Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BTG Plc Main Business Overview
13.4.5 BTG Plc Latest Developments
13.5 Eckert & Ziegler BEBIG
13.5.1 Eckert & Ziegler BEBIG Company Information
13.5.2 Eckert & Ziegler BEBIG Interventional Oncology Device Product Portfolios and Specifications
13.5.3 Eckert & Ziegler BEBIG Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Eckert & Ziegler BEBIG Main Business Overview
13.5.5 Eckert & Ziegler BEBIG Latest Developments
13.6 HealthTronics, Inc.
13.6.1 HealthTronics, Inc. Company Information
13.6.2 HealthTronics, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.6.3 HealthTronics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 HealthTronics, Inc. Main Business Overview
13.6.5 HealthTronics, Inc. Latest Developments
13.7 IceCure Medical
13.7.1 IceCure Medical Company Information
13.7.2 IceCure Medical Interventional Oncology Device Product Portfolios and Specifications
13.7.3 IceCure Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 IceCure Medical Main Business Overview
13.7.5 IceCure Medical Latest Developments
13.8 Medtronic PLC
13.8.1 Medtronic PLC Company Information
13.8.2 Medtronic PLC Interventional Oncology Device Product Portfolios and Specifications
13.8.3 Medtronic PLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Medtronic PLC Main Business Overview
13.8.5 Medtronic PLC Latest Developments
13.9 Medwaves, Inc.
13.9.1 Medwaves, Inc. Company Information
13.9.2 Medwaves, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.9.3 Medwaves, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Medwaves, Inc. Main Business Overview
13.9.5 Medwaves, Inc. Latest Developments
13.10 Merit Medical Systems, Inc.
13.10.1 Merit Medical Systems, Inc. Company Information
13.10.2 Merit Medical Systems, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.10.3 Merit Medical Systems, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merit Medical Systems, Inc. Main Business Overview
13.10.5 Merit Medical Systems, Inc. Latest Developments
13.11 Sanarus Technologies, Inc.
13.11.1 Sanarus Technologies, Inc. Company Information
13.11.2 Sanarus Technologies, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.11.3 Sanarus Technologies, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sanarus Technologies, Inc. Main Business Overview
13.11.5 Sanarus Technologies, Inc. Latest Developments
13.12 Sirtex Medical Ltd.
13.12.1 Sirtex Medical Ltd. Company Information
13.12.2 Sirtex Medical Ltd. Interventional Oncology Device Product Portfolios and Specifications
13.12.3 Sirtex Medical Ltd. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sirtex Medical Ltd. Main Business Overview
13.12.5 Sirtex Medical Ltd. Latest Developments
13.13 Sonacare Medical
13.13.1 Sonacare Medical Company Information
13.13.2 Sonacare Medical Interventional Oncology Device Product Portfolios and Specifications
13.13.3 Sonacare Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sonacare Medical Main Business Overview
13.13.5 Sonacare Medical Latest Developments
13.14 Terumo Corporation
13.14.1 Terumo Corporation Company Information
13.14.2 Terumo Corporation Interventional Oncology Device Product Portfolios and Specifications
13.14.3 Terumo Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Terumo Corporation Main Business Overview
13.14.5 Terumo Corporation Latest Developments
13.15 Trod Medical
13.15.1 Trod Medical Company Information
13.15.2 Trod Medical Interventional Oncology Device Product Portfolios and Specifications
13.15.3 Trod Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Trod Medical Main Business Overview
13.15.5 Trod Medical Latest Developments
13.16 Cook Meidical LLC
13.16.1 Cook Meidical LLC Company Information
13.16.2 Cook Meidical LLC Interventional Oncology Device Product Portfolios and Specifications
13.16.3 Cook Meidical LLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Cook Meidical LLC Main Business Overview
13.16.5 Cook Meidical LLC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Interventional Oncology Device Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Interventional Oncology Device Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Ablation Devices
Table 4. Major Players of Embolization Devices
Table 5. Major Players of Supporting Devices
Table 6. Major Players of Next Generation Devices
Table 7. Global Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 8. Global Interventional Oncology Device Sales Market Share by Type (2018-2023)
Table 9. Global Interventional Oncology Device Revenue by Type (2018-2023) & ($ million)
Table 10. Global Interventional Oncology Device Revenue Market Share by Type (2018-2023)
Table 11. Global Interventional Oncology Device Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 13. Global Interventional Oncology Device Sales Market Share by Application (2018-2023)
Table 14. Global Interventional Oncology Device Revenue by Application (2018-2023)
Table 15. Global Interventional Oncology Device Revenue Market Share by Application (2018-2023)
Table 16. Global Interventional Oncology Device Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Interventional Oncology Device Sales by Company (2018-2023) & (K Units)
Table 18. Global Interventional Oncology Device Sales Market Share by Company (2018-2023)
Table 19. Global Interventional Oncology Device Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Interventional Oncology Device Revenue Market Share by Company (2018-2023)
Table 21. Global Interventional Oncology Device Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Interventional Oncology Device Producing Area Distribution and Sales Area
Table 23. Players Interventional Oncology Device Products Offered
Table 24. Interventional Oncology Device Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Interventional Oncology Device Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Interventional Oncology Device Sales Market Share Geographic Region (2018-2023)
Table 29. Global Interventional Oncology Device Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Interventional Oncology Device Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Interventional Oncology Device Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Interventional Oncology Device Sales Market Share by Country/Region (2018-2023)
Table 33. Global Interventional Oncology Device Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Interventional Oncology Device Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Interventional Oncology Device Sales by Country (2018-2023) & (K Units)
Table 36. Americas Interventional Oncology Device Sales Market Share by Country (2018-2023)
Table 37. Americas Interventional Oncology Device Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Interventional Oncology Device Revenue Market Share by Country (2018-2023)
Table 39. Americas Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 40. Americas Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 41. APAC Interventional Oncology Device Sales by Region (2018-2023) & (K Units)
Table 42. APAC Interventional Oncology Device Sales Market Share by Region (2018-2023)
Table 43. APAC Interventional Oncology Device Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Interventional Oncology Device Revenue Market Share by Region (2018-2023)
Table 45. APAC Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 46. APAC Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 47. Europe Interventional Oncology Device Sales by Country (2018-2023) & (K Units)
Table 48. Europe Interventional Oncology Device Sales Market Share by Country (2018-2023)
Table 49. Europe Interventional Oncology Device Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Interventional Oncology Device Revenue Market Share by Country (2018-2023)
Table 51. Europe Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 52. Europe Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Interventional Oncology Device Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Interventional Oncology Device Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Interventional Oncology Device Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Interventional Oncology Device Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Interventional Oncology Device
Table 60. Key Market Challenges & Risks of Interventional Oncology Device
Table 61. Key Industry Trends of Interventional Oncology Device
Table 62. Interventional Oncology Device Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Interventional Oncology Device Distributors List
Table 65. Interventional Oncology Device Customer List
Table 66. Global Interventional Oncology Device Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Interventional Oncology Device Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Interventional Oncology Device Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Interventional Oncology Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Interventional Oncology Device Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Interventional Oncology Device Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Interventional Oncology Device Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Interventional Oncology Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Interventional Oncology Device Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Interventional Oncology Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Interventional Oncology Device Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Interventional Oncology Device Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Interventional Oncology Device Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Interventional Oncology Device Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. AngioDynamics, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 81. AngioDynamics, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 82. AngioDynamics, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. AngioDynamics, Inc. Main Business
Table 84. AngioDynamics, Inc. Latest Developments
Table 85. BD Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 86. BD Interventional Oncology Device Product Portfolios and Specifications
Table 87. BD Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. BD Main Business
Table 89. BD Latest Developments
Table 90. Boston Scientific Corporation Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 91. Boston Scientific Corporation Interventional Oncology Device Product Portfolios and Specifications
Table 92. Boston Scientific Corporation Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Boston Scientific Corporation Main Business
Table 94. Boston Scientific Corporation Latest Developments
Table 95. BTG Plc Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 96. BTG Plc Interventional Oncology Device Product Portfolios and Specifications
Table 97. BTG Plc Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. BTG Plc Main Business
Table 99. BTG Plc Latest Developments
Table 100. Eckert & Ziegler BEBIG Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 101. Eckert & Ziegler BEBIG Interventional Oncology Device Product Portfolios and Specifications
Table 102. Eckert & Ziegler BEBIG Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Eckert & Ziegler BEBIG Main Business
Table 104. Eckert & Ziegler BEBIG Latest Developments
Table 105. HealthTronics, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 106. HealthTronics, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 107. HealthTronics, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. HealthTronics, Inc. Main Business
Table 109. HealthTronics, Inc. Latest Developments
Table 110. IceCure Medical Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 111. IceCure Medical Interventional Oncology Device Product Portfolios and Specifications
Table 112. IceCure Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. IceCure Medical Main Business
Table 114. IceCure Medical Latest Developments
Table 115. Medtronic PLC Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 116. Medtronic PLC Interventional Oncology Device Product Portfolios and Specifications
Table 117. Medtronic PLC Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Medtronic PLC Main Business
Table 119. Medtronic PLC Latest Developments
Table 120. Medwaves, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 121. Medwaves, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 122. Medwaves, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Medwaves, Inc. Main Business
Table 124. Medwaves, Inc. Latest Developments
Table 125. Merit Medical Systems, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 126. Merit Medical Systems, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 127. Merit Medical Systems, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Merit Medical Systems, Inc. Main Business
Table 129. Merit Medical Systems, Inc. Latest Developments
Table 130. Sanarus Technologies, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 131. Sanarus Technologies, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 132. Sanarus Technologies, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Sanarus Technologies, Inc. Main Business
Table 134. Sanarus Technologies, Inc. Latest Developments
Table 135. Sirtex Medical Ltd. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 136. Sirtex Medical Ltd. Interventional Oncology Device Product Portfolios and Specifications
Table 137. Sirtex Medical Ltd. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Sirtex Medical Ltd. Main Business
Table 139. Sirtex Medical Ltd. Latest Developments
Table 140. Sonacare Medical Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 141. Sonacare Medical Interventional Oncology Device Product Portfolios and Specifications
Table 142. Sonacare Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Sonacare Medical Main Business
Table 144. Sonacare Medical Latest Developments
Table 145. Terumo Corporation Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 146. Terumo Corporation Interventional Oncology Device Product Portfolios and Specifications
Table 147. Terumo Corporation Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Terumo Corporation Main Business
Table 149. Terumo Corporation Latest Developments
Table 150. Trod Medical Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 151. Trod Medical Interventional Oncology Device Product Portfolios and Specifications
Table 152. Trod Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Trod Medical Main Business
Table 154. Trod Medical Latest Developments
Table 155. Cook Meidical LLC Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 156. Cook Meidical LLC Interventional Oncology Device Product Portfolios and Specifications
Table 157. Cook Meidical LLC Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Cook Meidical LLC Main Business
Table 159. Cook Meidical LLC Latest Developments
Table 1. Interventional Oncology Device Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Interventional Oncology Device Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Ablation Devices
Table 4. Major Players of Embolization Devices
Table 5. Major Players of Supporting Devices
Table 6. Major Players of Next Generation Devices
Table 7. Global Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 8. Global Interventional Oncology Device Sales Market Share by Type (2018-2023)
Table 9. Global Interventional Oncology Device Revenue by Type (2018-2023) & ($ million)
Table 10. Global Interventional Oncology Device Revenue Market Share by Type (2018-2023)
Table 11. Global Interventional Oncology Device Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 13. Global Interventional Oncology Device Sales Market Share by Application (2018-2023)
Table 14. Global Interventional Oncology Device Revenue by Application (2018-2023)
Table 15. Global Interventional Oncology Device Revenue Market Share by Application (2018-2023)
Table 16. Global Interventional Oncology Device Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Interventional Oncology Device Sales by Company (2018-2023) & (K Units)
Table 18. Global Interventional Oncology Device Sales Market Share by Company (2018-2023)
Table 19. Global Interventional Oncology Device Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Interventional Oncology Device Revenue Market Share by Company (2018-2023)
Table 21. Global Interventional Oncology Device Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Interventional Oncology Device Producing Area Distribution and Sales Area
Table 23. Players Interventional Oncology Device Products Offered
Table 24. Interventional Oncology Device Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Interventional Oncology Device Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Interventional Oncology Device Sales Market Share Geographic Region (2018-2023)
Table 29. Global Interventional Oncology Device Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Interventional Oncology Device Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Interventional Oncology Device Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Interventional Oncology Device Sales Market Share by Country/Region (2018-2023)
Table 33. Global Interventional Oncology Device Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Interventional Oncology Device Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Interventional Oncology Device Sales by Country (2018-2023) & (K Units)
Table 36. Americas Interventional Oncology Device Sales Market Share by Country (2018-2023)
Table 37. Americas Interventional Oncology Device Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Interventional Oncology Device Revenue Market Share by Country (2018-2023)
Table 39. Americas Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 40. Americas Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 41. APAC Interventional Oncology Device Sales by Region (2018-2023) & (K Units)
Table 42. APAC Interventional Oncology Device Sales Market Share by Region (2018-2023)
Table 43. APAC Interventional Oncology Device Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Interventional Oncology Device Revenue Market Share by Region (2018-2023)
Table 45. APAC Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 46. APAC Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 47. Europe Interventional Oncology Device Sales by Country (2018-2023) & (K Units)
Table 48. Europe Interventional Oncology Device Sales Market Share by Country (2018-2023)
Table 49. Europe Interventional Oncology Device Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Interventional Oncology Device Revenue Market Share by Country (2018-2023)
Table 51. Europe Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 52. Europe Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Interventional Oncology Device Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Interventional Oncology Device Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Interventional Oncology Device Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Interventional Oncology Device Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Interventional Oncology Device Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Interventional Oncology Device Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Interventional Oncology Device
Table 60. Key Market Challenges & Risks of Interventional Oncology Device
Table 61. Key Industry Trends of Interventional Oncology Device
Table 62. Interventional Oncology Device Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Interventional Oncology Device Distributors List
Table 65. Interventional Oncology Device Customer List
Table 66. Global Interventional Oncology Device Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Interventional Oncology Device Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Interventional Oncology Device Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Interventional Oncology Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Interventional Oncology Device Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Interventional Oncology Device Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Interventional Oncology Device Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Interventional Oncology Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Interventional Oncology Device Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Interventional Oncology Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Interventional Oncology Device Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Interventional Oncology Device Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Interventional Oncology Device Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Interventional Oncology Device Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. AngioDynamics, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 81. AngioDynamics, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 82. AngioDynamics, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. AngioDynamics, Inc. Main Business
Table 84. AngioDynamics, Inc. Latest Developments
Table 85. BD Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 86. BD Interventional Oncology Device Product Portfolios and Specifications
Table 87. BD Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. BD Main Business
Table 89. BD Latest Developments
Table 90. Boston Scientific Corporation Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 91. Boston Scientific Corporation Interventional Oncology Device Product Portfolios and Specifications
Table 92. Boston Scientific Corporation Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Boston Scientific Corporation Main Business
Table 94. Boston Scientific Corporation Latest Developments
Table 95. BTG Plc Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 96. BTG Plc Interventional Oncology Device Product Portfolios and Specifications
Table 97. BTG Plc Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. BTG Plc Main Business
Table 99. BTG Plc Latest Developments
Table 100. Eckert & Ziegler BEBIG Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 101. Eckert & Ziegler BEBIG Interventional Oncology Device Product Portfolios and Specifications
Table 102. Eckert & Ziegler BEBIG Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Eckert & Ziegler BEBIG Main Business
Table 104. Eckert & Ziegler BEBIG Latest Developments
Table 105. HealthTronics, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 106. HealthTronics, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 107. HealthTronics, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. HealthTronics, Inc. Main Business
Table 109. HealthTronics, Inc. Latest Developments
Table 110. IceCure Medical Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 111. IceCure Medical Interventional Oncology Device Product Portfolios and Specifications
Table 112. IceCure Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. IceCure Medical Main Business
Table 114. IceCure Medical Latest Developments
Table 115. Medtronic PLC Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 116. Medtronic PLC Interventional Oncology Device Product Portfolios and Specifications
Table 117. Medtronic PLC Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Medtronic PLC Main Business
Table 119. Medtronic PLC Latest Developments
Table 120. Medwaves, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 121. Medwaves, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 122. Medwaves, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Medwaves, Inc. Main Business
Table 124. Medwaves, Inc. Latest Developments
Table 125. Merit Medical Systems, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 126. Merit Medical Systems, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 127. Merit Medical Systems, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Merit Medical Systems, Inc. Main Business
Table 129. Merit Medical Systems, Inc. Latest Developments
Table 130. Sanarus Technologies, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 131. Sanarus Technologies, Inc. Interventional Oncology Device Product Portfolios and Specifications
Table 132. Sanarus Technologies, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Sanarus Technologies, Inc. Main Business
Table 134. Sanarus Technologies, Inc. Latest Developments
Table 135. Sirtex Medical Ltd. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 136. Sirtex Medical Ltd. Interventional Oncology Device Product Portfolios and Specifications
Table 137. Sirtex Medical Ltd. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Sirtex Medical Ltd. Main Business
Table 139. Sirtex Medical Ltd. Latest Developments
Table 140. Sonacare Medical Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 141. Sonacare Medical Interventional Oncology Device Product Portfolios and Specifications
Table 142. Sonacare Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Sonacare Medical Main Business
Table 144. Sonacare Medical Latest Developments
Table 145. Terumo Corporation Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 146. Terumo Corporation Interventional Oncology Device Product Portfolios and Specifications
Table 147. Terumo Corporation Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Terumo Corporation Main Business
Table 149. Terumo Corporation Latest Developments
Table 150. Trod Medical Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 151. Trod Medical Interventional Oncology Device Product Portfolios and Specifications
Table 152. Trod Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Trod Medical Main Business
Table 154. Trod Medical Latest Developments
Table 155. Cook Meidical LLC Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 156. Cook Meidical LLC Interventional Oncology Device Product Portfolios and Specifications
Table 157. Cook Meidical LLC Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Cook Meidical LLC Main Business
Table 159. Cook Meidical LLC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Interventional Oncology Device
Figure 2. Interventional Oncology Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Interventional Oncology Device Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Interventional Oncology Device Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Interventional Oncology Device Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Ablation Devices
Figure 10. Product Picture of Embolization Devices
Figure 11. Product Picture of Supporting Devices
Figure 12. Product Picture of Next Generation Devices
Figure 13. Global Interventional Oncology Device Sales Market Share by Type in 2022
Figure 14. Global Interventional Oncology Device Revenue Market Share by Type (2018-2023)
Figure 15. Interventional Oncology Device Consumed in Hospitals
Figure 16. Global Interventional Oncology Device Market: Hospitals (2018-2023) & (K Units)
Figure 17. Interventional Oncology Device Consumed in Specialty Clinics and Ambulatory Surgical Centers
Figure 18. Global Interventional Oncology Device Market: Specialty Clinics and Ambulatory Surgical Centers (2018-2023) & (K Units)
Figure 19. Interventional Oncology Device Consumed in Others (Homecare and Research Institutes)
Figure 20. Global Interventional Oncology Device Market: Others (Homecare and Research Institutes) (2018-2023) & (K Units)
Figure 21. Global Interventional Oncology Device Sales Market Share by Application (2022)
Figure 22. Global Interventional Oncology Device Revenue Market Share by Application in 2022
Figure 23. Interventional Oncology Device Sales Market by Company in 2022 (K Units)
Figure 24. Global Interventional Oncology Device Sales Market Share by Company in 2022
Figure 25. Interventional Oncology Device Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Interventional Oncology Device Revenue Market Share by Company in 2022
Figure 27. Global Interventional Oncology Device Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Interventional Oncology Device Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Interventional Oncology Device Sales 2018-2023 (K Units)
Figure 30. Americas Interventional Oncology Device Revenue 2018-2023 ($ Millions)
Figure 31. APAC Interventional Oncology Device Sales 2018-2023 (K Units)
Figure 32. APAC Interventional Oncology Device Revenue 2018-2023 ($ Millions)
Figure 33. Europe Interventional Oncology Device Sales 2018-2023 (K Units)
Figure 34. Europe Interventional Oncology Device Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Interventional Oncology Device Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Interventional Oncology Device Revenue 2018-2023 ($ Millions)
Figure 37. Americas Interventional Oncology Device Sales Market Share by Country in 2022
Figure 38. Americas Interventional Oncology Device Revenue Market Share by Country in 2022
Figure 39. Americas Interventional Oncology Device Sales Market Share by Type (2018-2023)
Figure 40. Americas Interventional Oncology Device Sales Market Share by Application (2018-2023)
Figure 41. United States Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Interventional Oncology Device Sales Market Share by Region in 2022
Figure 46. APAC Interventional Oncology Device Revenue Market Share by Regions in 2022
Figure 47. APAC Interventional Oncology Device Sales Market Share by Type (2018-2023)
Figure 48. APAC Interventional Oncology Device Sales Market Share by Application (2018-2023)
Figure 49. China Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Interventional Oncology Device Sales Market Share by Country in 2022
Figure 57. Europe Interventional Oncology Device Revenue Market Share by Country in 2022
Figure 58. Europe Interventional Oncology Device Sales Market Share by Type (2018-2023)
Figure 59. Europe Interventional Oncology Device Sales Market Share by Application (2018-2023)
Figure 60. Germany Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Interventional Oncology Device Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Interventional Oncology Device Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Interventional Oncology Device Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Interventional Oncology Device Sales Market Share by Application (2018-2023)
Figure 69. Egypt Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Interventional Oncology Device in 2022
Figure 75. Manufacturing Process Analysis of Interventional Oncology Device
Figure 76. Industry Chain Structure of Interventional Oncology Device
Figure 77. Channels of Distribution
Figure 78. Global Interventional Oncology Device Sales Market Forecast by Region (2024-2029)
Figure 79. Global Interventional Oncology Device Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Interventional Oncology Device Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Interventional Oncology Device Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Interventional Oncology Device Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Interventional Oncology Device Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Interventional Oncology Device
Figure 2. Interventional Oncology Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Interventional Oncology Device Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Interventional Oncology Device Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Interventional Oncology Device Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Ablation Devices
Figure 10. Product Picture of Embolization Devices
Figure 11. Product Picture of Supporting Devices
Figure 12. Product Picture of Next Generation Devices
Figure 13. Global Interventional Oncology Device Sales Market Share by Type in 2022
Figure 14. Global Interventional Oncology Device Revenue Market Share by Type (2018-2023)
Figure 15. Interventional Oncology Device Consumed in Hospitals
Figure 16. Global Interventional Oncology Device Market: Hospitals (2018-2023) & (K Units)
Figure 17. Interventional Oncology Device Consumed in Specialty Clinics and Ambulatory Surgical Centers
Figure 18. Global Interventional Oncology Device Market: Specialty Clinics and Ambulatory Surgical Centers (2018-2023) & (K Units)
Figure 19. Interventional Oncology Device Consumed in Others (Homecare and Research Institutes)
Figure 20. Global Interventional Oncology Device Market: Others (Homecare and Research Institutes) (2018-2023) & (K Units)
Figure 21. Global Interventional Oncology Device Sales Market Share by Application (2022)
Figure 22. Global Interventional Oncology Device Revenue Market Share by Application in 2022
Figure 23. Interventional Oncology Device Sales Market by Company in 2022 (K Units)
Figure 24. Global Interventional Oncology Device Sales Market Share by Company in 2022
Figure 25. Interventional Oncology Device Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Interventional Oncology Device Revenue Market Share by Company in 2022
Figure 27. Global Interventional Oncology Device Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Interventional Oncology Device Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Interventional Oncology Device Sales 2018-2023 (K Units)
Figure 30. Americas Interventional Oncology Device Revenue 2018-2023 ($ Millions)
Figure 31. APAC Interventional Oncology Device Sales 2018-2023 (K Units)
Figure 32. APAC Interventional Oncology Device Revenue 2018-2023 ($ Millions)
Figure 33. Europe Interventional Oncology Device Sales 2018-2023 (K Units)
Figure 34. Europe Interventional Oncology Device Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Interventional Oncology Device Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Interventional Oncology Device Revenue 2018-2023 ($ Millions)
Figure 37. Americas Interventional Oncology Device Sales Market Share by Country in 2022
Figure 38. Americas Interventional Oncology Device Revenue Market Share by Country in 2022
Figure 39. Americas Interventional Oncology Device Sales Market Share by Type (2018-2023)
Figure 40. Americas Interventional Oncology Device Sales Market Share by Application (2018-2023)
Figure 41. United States Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Interventional Oncology Device Sales Market Share by Region in 2022
Figure 46. APAC Interventional Oncology Device Revenue Market Share by Regions in 2022
Figure 47. APAC Interventional Oncology Device Sales Market Share by Type (2018-2023)
Figure 48. APAC Interventional Oncology Device Sales Market Share by Application (2018-2023)
Figure 49. China Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Interventional Oncology Device Sales Market Share by Country in 2022
Figure 57. Europe Interventional Oncology Device Revenue Market Share by Country in 2022
Figure 58. Europe Interventional Oncology Device Sales Market Share by Type (2018-2023)
Figure 59. Europe Interventional Oncology Device Sales Market Share by Application (2018-2023)
Figure 60. Germany Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Interventional Oncology Device Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Interventional Oncology Device Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Interventional Oncology Device Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Interventional Oncology Device Sales Market Share by Application (2018-2023)
Figure 69. Egypt Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Interventional Oncology Device Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Interventional Oncology Device in 2022
Figure 75. Manufacturing Process Analysis of Interventional Oncology Device
Figure 76. Industry Chain Structure of Interventional Oncology Device
Figure 77. Channels of Distribution
Figure 78. Global Interventional Oncology Device Sales Market Forecast by Region (2024-2029)
Figure 79. Global Interventional Oncology Device Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Interventional Oncology Device Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Interventional Oncology Device Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Interventional Oncology Device Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Interventional Oncology Device Revenue Market Share Forecast by Application (2024-2029)
